Kala Pharmaceuticals named Marjan Farid, M.D. to its board of directors Monday.
Dr. Farid currently serves as a professor of clinical ophthalmology, director of cornea, refractive and cataract surgery, and Vice Chair of Ophthalmic Faculty at the Gavin Herbert Eye Institute at the University of California, Irvine. He also founded the Severe Ocular Surface Disease Center at UCI.
“I have devoted my career to treating people living with severe ocular surface diseases, which, left untreated, can lead to significant vision loss or blindness,” Farid said in a statement. “I am deeply familiar with the challenges associated with these conditions and the limited options available to patients and their physicians, and am committed to helping advance a new generation of medicines that can address the underlying pathology and deliver significant clinical benefit.”
